These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 15580249)

  • 1. Combination stroke therapy: easy as APC?
    Lo EH
    Nat Med; 2004 Dec; 10(12):1295-6. PubMed ID: 15580249
    [No Abstract]   [Full Text] [Related]  

  • 2. Functional recovery after embolic stroke in rodents by activated protein C.
    Zlokovic BV; Zhang C; Liu D; Fernandez J; Griffin JH; Chopp M
    Ann Neurol; 2005 Sep; 58(3):474-7. PubMed ID: 16130108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytoprotective-selective activated protein C therapy for ischaemic stroke.
    Mosnier LO; Zlokovic BV; Griffin JH
    Thromb Haemost; 2014 Nov; 112(5):883-92. PubMed ID: 25230930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multitargeted effects of statin-enhanced thrombolytic therapy for stroke with recombinant human tissue-type plasminogen activator in the rat.
    Zhang L; Zhang ZG; Ding GL; Jiang Q; Liu X; Meng H; Hozeska A; Zhang C; Li L; Morris D; Zhang RL; Lu M; Chopp M
    Circulation; 2005 Nov; 112(22):3486-94. PubMed ID: 16316970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous activated protein C predicts hemorrhagic transformation and mortality after tissue plasminogen activator treatment in stroke patients.
    Mendioroz M; Fernández-Cadenas I; Alvarez-Sabín J; Rosell A; Quiroga D; Cuadrado E; Delgado P; Rubiera M; Ribó M; Molina C; Montaner J
    Cerebrovasc Dis; 2009; 28(2):143-50. PubMed ID: 19546541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stroke biomarkers: Can they help us to guide stroke thrombolysis?
    Montaner J
    Drug News Perspect; 2006 Nov; 19(9):523-32. PubMed ID: 17220957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein C and its inhibitor in malignancy.
    Suzuki K; Hayashi T
    Semin Thromb Hemost; 2007 Oct; 33(7):667-72. PubMed ID: 18000793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum S100B indicates successful combination treatment with recombinant tissue plasminogen activator and MK-801 in a rat model of embolic stroke.
    Tanaka Y; Marumo T; Omura T; Yoshida S
    Brain Res; 2007 Jun; 1154():194-9. PubMed ID: 17475227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of embolic stroke in rats with bortezomib and recombinant human tissue plasminogen activator.
    Zhang L; Zhang ZG; Liu X; Hozeska A; Stagliano N; Riordan W; Lu M; Chopp M
    Thromb Haemost; 2006 Jan; 95(1):166-73. PubMed ID: 16543976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Thrombolytic treatment in stroke in patients with intracardiac thrombus: presentation of one case].
    Segura T; Herrera M; Garcia-Muñozguren S; Zorita MD
    Neurologia; 2005 Apr; 20(3):149-52. PubMed ID: 15815951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant tissue plasminogen activator (rtPA) for stroke. The perspective at 8 years.
    Frey JL
    Neurologist; 2005 Mar; 11(2):123-33. PubMed ID: 15733334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue plasminogen activator-induced reperfusion injury after stroke revisited.
    Hermann DM; Matter CM
    Circulation; 2007 Jul; 116(4):363-5. PubMed ID: 17646593
    [No Abstract]   [Full Text] [Related]  

  • 13. Melatonin attenuates the postischemic increase in blood-brain barrier permeability and decreases hemorrhagic transformation of tissue-plasminogen activator therapy following ischemic stroke in mice.
    Chen TY; Lee MY; Chen HY; Kuo YL; Lin SC; Wu TS; Lee EJ
    J Pineal Res; 2006 Apr; 40(3):242-50. PubMed ID: 16499561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of tissue plasminogen activator, ischemic stroke, and potential legal issues.
    Liang BA; Lew R; Zivin JA
    Arch Neurol; 2008 Nov; 65(11):1429-33. PubMed ID: 19001160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial protein C receptor is expressed in rat cortical and hippocampal neurons and is necessary for protective effect of activated protein C at glutamate excitotoxicity.
    Gorbacheva L; Davidova O; Sokolova E; Ishiwata S; Pinelis V; Strukova S; Reiser G
    J Neurochem; 2009 Nov; 111(4):967-75. PubMed ID: 19780891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. tPA and proteolysis in the neurovascular unit.
    Lo EH; Broderick JP; Moskowitz MA
    Stroke; 2004 Feb; 35(2):354-6. PubMed ID: 14757877
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of activated protein C on neonatal hypoxic ischemic brain injury.
    Yesilirmak DC; Kumral A; Tugyan K; Cilaker S; Baskin H; Yilmaz O; Duman N; Ozkan H
    Brain Res; 2008 May; 1210():56-62. PubMed ID: 18420181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of acute ischemic apoplexy].
    Andersen G; Krieger DW; Iversen HK
    Ugeskr Laeger; 2009 Mar; 171(13):1094. PubMed ID: 19321089
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of applied cases of thrombolytic therapy against ultra-acute ischemic stroke. Using the Japanese Standard Stroke Registry Database.
    Shiotsuki H; Ogushi Y; Fushimi K; Kobayashi S;
    Tokai J Exp Clin Med; 2005 Apr; 30(1):49-62. PubMed ID: 15952299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The lipophilic multifunctional antioxidant edaravone (radicut) improves behavior following embolic strokes in rabbits: a combination therapy study with tissue plasminogen activator.
    Lapchak PA; Zivin JA
    Exp Neurol; 2009 Jan; 215(1):95-100. PubMed ID: 18851964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.